Infusion of an antialpha4 integrin antibody is associated with less neoadventitial formation after balloon injury of porcine coronary arteries

Canadian Journal of Cardiology

Volumn 16, Issue 2, 2000, Pages 187-196

  Labinaz, Marino ^a   Hoffert, Cyrla ^a   Pels, Klaus ^a   Aggarwal, Sanjay ^a   Pepinsky, R Blake ^b   Leone, Diane ^b   Koteliansky, Victor ^b   Lobb, Roy R ^b   O'Brien, Edward R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b BIOGEN   (United States)

Author keywords

Antigens; Remodelling; Restenosis

Indexed keywords

BETA1 INTEGRIN; BRETYLIUM; HEPARIN; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; HOMING RECEPTOR; INTEGRIN; VERY LATE ACTIVATION ANTIGEN 4;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; BALLOON DILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DOUBLE BLIND PROCEDURE; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SWINE; ANIMAL; CORONARY BLOOD VESSEL; FIBROMUSCULAR DYSPLASIA; HUMAN; IMMUNOLOGY; INJURY; INTIMA; LYMPHOCYTE COUNT; PATHOLOGY; PHYSIOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTIBODIES, MONOCLONAL; CORONARY VESSELS; FIBROMUSCULAR DYSPLASIA; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; LYMPHOCYTE COUNT; RECEPTORS, LYMPHOCYTE HOMING; SWINE; TUNICA INTIMA;

EID: 0033622040     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994;89:2816-21.
2. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 1996;94:35-43.
3. Pasterkamp G, Borst C, Post MJ, et al. Atherosclerotic arterial remodeling in the superficial femoral artery. Individual variation in local compensatory enlargement response. Circulation 1996;93:1818-25.
4. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 1994;89:2809-15.
5. Andersen HR, Maeng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury. Insights from a porcine coronary (re)stenosis model. Circulation 1996;93:1716-24.
6. Shi Y, O'Brien J, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996;94:1655-64.
7. Scott NA, Gustavo D, Cipolla DVM, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93:2178-87.
8. Shi Y, O'Brien JE, Ala-Kokko L, Chung W, Mannion JD, Zalewski A. Origin of extracellular matrix synthesis during coronary repair. Circulation 1997;95:997-1006.
9. Isner JM. Vascular remodeling. Honey, I think I shrunk the artery. Circulation 1994;89:2937-41.
10. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-20.
11. Labinaz M, Pels K, Hoffert C, Aggarwal S, O'Brien ER. The time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res 1999;41:255-66.
12. Pels K, Labinaz M, Hoffert C, O'Brien ER. Adventitial angiogenesis early after coronary angioplasty is followed by microvessel regression and arterial narrowing. Arterioscler Thromb Vasc Biol 1999;19:229-38.
13. Shi Y, O'Brien J, Fard A, Zalewski A. Transforming growth factor-β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 1997;16:1298-305.
14. 4 integrins in vivo. J Clin Invest 1994;94:1722-8.
15. Pulido R, Elices MJ, Campanero MR, et al. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J Biol Chem 1991;266:10241-5.
16. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-84.
17. Kling D, Fingerle J, Harlan JM, Lobb RR, Lang F. Mononuclear leukocytes invade rabbit arterial intima during thickening formation via CD18- and VLA-4-dependent mechanisms and stimulate smooth muscle migration. Circ Res 1995;77:1121-8.
18. Molossi S, Elices M, Arrhenius T, Diaz R, Coulber C, Rabinovitch M. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J Clin Invest 1995;95:2601-10.
19. Sadahiro M, McDonald TO, Allen MD. Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors. Am J Pathol 1993;142:675-83.
20. Lumsden AB, Chen C, Hughes JD, Kelly AB, Hanson S, Harker L. Anti-VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in non-human primates. J Vasc Surg 1997;26:87-93.
21. Lobb RR, Antognetti G, Pepinsky RB, Burkly LC, Leone DR, Whitty A. A direct binding assay for the vascular cell adhesion molecule-1 (VCAM1) interaction with alpha 4 integrins. Cell Adhes Commun 1995;3:385-97.
22. Garvin MR, Labinaz M, Pels K, Walley VM, Mizgala HF, O'Brien ER. Arterial expression of the plasminogen activator system early after cardiac transplantation. Cardiovasc Res 1999;35:241-9.
23. Waksman R, Rodriguez JC, Robinson K, et al. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1998;96:1944-52.
24. Lumsden AB, Chen C, Hughes JD, Kelly AB, Hanson S, Harker L. Anti-VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in non-human primates. J Vasc Surg 1997;26:87-93.
25. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis after balloon angioplasty: a practical proliferative model in corcine coronary arteries. Circulation 1990;82:2190-200.
26. Schwartz RS, Edwards WD, Murphy JG, Camrud AR, Holmes DR. Restenosis develops in four stages: serial histologic studies in a coronary injury model. J Am Coll Cardiol 1991;17:52A.
27. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-74.
28. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci 1993;90:9374-8.
29. Falk E, Fallon JT, Mailhac A, et al. Muramidase. A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease. Cardiovasc Pathol 1994;3:183-9.
30. Schwartz RS, Holmes Jr DR, Topol EJ. The restenosis paradigm revisted: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-93.
31. Lincoff AM, Tcheng JE, Califf RM, et al. The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization. Circulation 1998;98:1767. (Abst)